Clinical Trial Analysisfor "Trastuzumab Injection"
Study Phases Distribution
Distribution of trials by study phase
Phase 2: 3
Phase 3: 3
Phase 1: 2
Not Applicable: 1
Recruitment Status Distribution
Distribution of trials by recruitment status
Total: 10
Top Countries Distribution
Countries with most clinical trials
Top Companies Distribution
Companies with most clinical trials
| Company | Count |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Genor Biopharma Co., Ltd. | 1 |
| Jiangsu Famous Medical Technology Co., Ltd. | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| RemeGen Co., Ltd. | 1 |
| Shanghai Miracogen Inc. | 1 |
| Spanish Breast Cancer Research Group | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| University Medical Center Groningen | 1 |
Top Conditions Distribution
Most studied medical conditions
| Condition | Count |
|---|---|
| Metastatic Breast Cancer | 4 |
| Advanced Breast Cancer | 1 |
| Breast Cancer | 1 |
| Gastric Cancer | 1 |
| HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy | 1 |
| HER2+ Breast Cancer | 1 |
| HER2-PositiveRecurrent or Metastatic Breast Cancer | 1 |
| HER2-positive Breast Cancer | 1 |
| Metastatic Gastric Cancer | 1 |
Top Interventions Distribution
Most common intervention types
| Intervention | Count |
|---|---|
| Trastuzumab Injection | 3 |
| Trastuzumab Emtansine for Injection | 2 |
| 89Zr-trastuzumab injection | 1 |
| Capecitabine | 1 |
| Coprelotamab Injection | 1 |
| Herceptin | 1 |
| MRG002 | 1 |
| Oxaliplatin injection | 1 |
| Perjeta + Trastuzumab + Docetaxel | 1 |
| Pyrotinib Maleate Tablets | 1 |